首頁 > SCI期刊 > SCI期刊 > SCIE期刊 > 期刊介紹
評價信息:
影響因子:2.012
《亞太臨床腫瘤學(xué)雜志》(Asia-pacific Journal Of Clinical Oncology)是一本國際期刊。該刊由WILEY出版商創(chuàng)刊于2005年,刊期6 issues/year。該刊已被國際重要權(quán)威數(shù)據(jù)庫SCI、SCIE收錄。
Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care. The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations. In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications. Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review. The Journal encourages clinical studies, particularly prospectively designed clinical trials.
《亞太臨床腫瘤學(xué)雜志》是一本多學(xué)科的腫瘤學(xué)雜志,旨在成為一個促進(jìn)合作和交流信息的論壇,以了解亞太地區(qū)不同國家在癌癥治療和護(hù)理方面的情況。該雜志非常適合發(fā)表與種族、文化、經(jīng)濟(jì)和其他人群差異有關(guān)的癌癥行為、管理和結(jié)果多樣性的出版物。除了原創(chuàng)文章外,該雜志還發(fā)表評論、社論、致編輯的信和簡短通訊。病例報告通常不考慮發(fā)表,只有編輯認(rèn)為具有非凡腫瘤學(xué)價值的優(yōu)秀論文才可能被考慮審閱。該雜志鼓勵臨床研究,尤其是前瞻性設(shè)計的臨床試驗。
《Asia-pacific Journal Of Clinical Oncology》(亞太臨床腫瘤學(xué)雜志)編輯部通訊方式為Asia-Pac. J. Clin. Oncol.。如果您需要協(xié)助投稿或潤稿服務(wù),您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年,熟悉發(fā)表政策,可為您提供一對一投稿指導(dǎo),避免您在投稿時頻繁碰壁,節(jié)省您的寶貴時間,有效提升發(fā)表機(jī)率,確保SCI檢索(檢索不了全額退款)。我們視信譽為生命,多方面確保文章安全保密,在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。
Gold OA文章占比 | 研究類文章占比 | 文章自引率 |
-- | -- | -- |
開源占比 | 出版國人文章占比 | OA被引用占比 |
0.11... | 0.08 | 0.07... |
名詞解釋:JCR分區(qū)在學(xué)術(shù)期刊評價、科研成果展示、科研方向引導(dǎo)以及學(xué)術(shù)交流與合作等方面都具有重要的價值。通過對期刊影響因子的精確計算和細(xì)致劃分,JCR分區(qū)能夠清晰地反映出不同期刊在同一學(xué)科領(lǐng)域內(nèi)的相對位置,從而幫助科研人員準(zhǔn)確識別出高質(zhì)量的學(xué)術(shù)期刊。
歷年引文指標(biāo)和發(fā)文量
2019-2021年國家/地區(qū)發(fā)文量統(tǒng)計
國家/地區(qū) | 數(shù)量 |
Australia | 1151 |
CHINA MAINLAND | 147 |
USA | 106 |
Japan | 61 |
England | 54 |
South Korea | 38 |
Canada | 36 |
Singapore | 32 |
France | 28 |
Taiwan | 28 |
2019-2021年機(jī)構(gòu)發(fā)文量統(tǒng)計
機(jī)構(gòu) | 數(shù)量 |
UNIVERSITY OF SYDNEY | 234 |
UNIVERSITY OF NEWCASTLE | 175 |
PETER MACCALLUM CANCER CENTER | 144 |
UNIVERSITY OF MELBOURNE | 109 |
UNIVERSITY OF NEW SOUTH WALES SYDNEY | 103 |
HUNTER MEDICAL RESEARCH INSTITUTE | 102 |
MONASH UNIVERSITY | 91 |
UNIVERSITY OF QUEENSLAND | 88 |
UNIVERSITY OF WESTERN AUSTRALIA | 77 |
CALVARY MATER NEWCASTLE HOSPITAL | 76 |
2019-2021年文章引用數(shù)據(jù)
文章引用名稱 | 引用次數(shù) |
Biomarkers and therapeutic advances in g... | 26 |
Metastatic triple negative breast cancer... | 17 |
Strain-specific probiotic (microbial cel... | 13 |
PD-L1 expression associated with worse s... | 13 |
Identifying the most prevalent unmet nee... | 13 |
The impacts of pretreatment circulating ... | 12 |
Cancer multidisciplinary team meetings i... | 11 |
Exosomal tetraspanins as regulators of c... | 10 |
Primary thromboprophylaxis (PTP) in ambu... | 10 |
Clinical response to apatinib monotherap... | 9 |
2019-2021年文章被引用數(shù)據(jù)
被引用期刊名稱 | 數(shù)量 |
SUPPORT CARE CANCER | 24 |
ASIA-PAC J CLIN ONCO | 23 |
FRONT ONCOL | 23 |
BMC CANCER | 18 |
FUTURE ONCOL | 18 |
BMJ OPEN | 15 |
CANCERS | 15 |
COCHRANE DB SYST REV | 15 |
ONCOL LETT | 15 |
MEDICINE | 14 |
2019-2021年引用數(shù)據(jù)
引用期刊名稱 | 數(shù)量 |
J CLIN ONCOL | 209 |
ANN ONCOL | 84 |
LANCET ONCOL | 80 |
INT J RADIAT ONCOL | 75 |
NEW ENGL J MED | 73 |
CANCER-AM CANCER SOC | 72 |
EUR J CANCER | 52 |
EUR UROL | 43 |
BRIT J CANCER | 41 |
LANCET | 37 |
若用戶需要出版服務(wù),請聯(lián)系出版商:Asia-Pac. J. Clin. Oncol.。